Cargando…
PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy
OBJECTIVE: To assess retention, dosing, efficacy, and safety of perampanel in a large cohort of patients with epilepsy during routine clinical care. METHODS: PROVE was a retrospective, non‐interventional Phase IV study (NCT03208660). Data were obtained retrospectively from the medical records of pat...
Autores principales: | Wechsler, Robert T., Wheless, James, Zafar, Muhammad, Huesmann, Graham R., Lancman, Marcelo, Segal, Eric, Chez, Michael, Aboumatar, Sami, Patten, Anna, Salah, Alejandro, Malhotra, Manoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159249/ https://www.ncbi.nlm.nih.gov/pubmed/34942053 http://dx.doi.org/10.1002/epi4.12575 |
Ejemplares similares
-
Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
por: Wheless, James, et al.
Publicado: (2020) -
Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022) -
Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
por: Faught, Edward, et al.
Publicado: (2021) -
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: A randomized trial
por: French, Jacqueline A., et al.
Publicado: (2015) -
Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020)